General Info

Saebo, Inc, is a leading global provider of innovative rehabilitation products for stroke survivors and other neurologically impaired individuals. Headquartered in in Charlotte NC, the company was founded in 2001 by two occupational therapists specializing in stroke rehabilitation. As the leading cause of long-term disability in the U.S., stroke affects over 700, 000 Americans every year, leaving many with crippling side affects including the loss of hand function. Saebo's pioneering treatment protocols are based on new research documenting the brain's remarkable ability to re-program itself following injury. The company's neurological orthotic devices, including the ground-breaking SaeboFlex and SaeboReach, allow patients with very little residual arm and hand function to immediately begin performing task-oriented, grasp and release activities, thereby forging new pathways in the brain. Named Most Valuable Product in 2008 by Therapy Times, the Saebo Program is now offered as a treatment option at over 2, 000 clinics and hospitals nationwide, including 22 of the Top 25 Rehabilitation Hospitals as ranked by U.S. News & World Report. The Saebo orthoses are also eligible for reimbursement by Medicare and most commercial insurers. With a network of over 4, 500 trained clinicians spanning four continents, Saebo is committed to helping stroke survivors around the globe achieve a new level of independence. You may be eligible to receive Saebo Products at little or no cost to you. To find out whether you may qualify, call 888-284-5433. Saebo, Inc Announces Delivery of its 50th InPatient Kit ; Global Demand Driving New Sales Largest Private Hospital in Saudi Arabia Expands Relationship with Saebo Saebo Introduces Outpatient Evaluation Kit Saebo, Inc, is a leading global provider of innovative rehabilitation products for stroke survivors and other neurologically impaired individuals. Headquartered in in Charlotte NC, the company was founded in 2001 by two occupational therapists specializing in stroke rehabilitation. As the leading cause of long-term disability in the U.S., stroke affects over 700, 000 Americans every year, leaving many with crippling side affects including the loss of hand function. Saebo's pioneering treatment protocols are based on new research documenting the brain's remarkable ability to re-program itself following injury. The company's neurological orthotic devices, including the ground-breaking SaeboFlex and SaeboReach, allow patients with very little residual arm and hand function to immediately begin performing task-oriented, grasp and release activities, thereby forging new pathways in the brain. Named Most Valuable Product in 2008 by Therapy Times, the Saebo Program is now offered as a treatment option at over 2, 000 clinics and hospitals nationwide, including 22 of the Top 25 Rehabilitation Hospitals as ranked by U.S. News & World Report. The Saebo orthoses are also eligible for reimbursement by Medicare and most commercial insurers. With a network of over 4, 500 trained clinicians spanning four continents, Saebo is committed to helping stroke survivors around the globe achieve a new level of independence.